2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$291,476
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); SENATE; Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Government Accountability Office (GAO)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Office of Management & Budget (OMB); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); White House Office; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Medicare Payment Advisory Commission (MedPAC)

Health Issues HCR

American Health Care Act; Better Care Reconciliation Act; Patient Choice & Quality Care Act; Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); White House Office; Executive Office of the President (EOP)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act; Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); White House Office; Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Budget/Appropriations BUD

National Health Service Corps; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: White House Office; Government Accountability Office (GAO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB)

Insurance INS

American Health Care Act; Better Care Reconciliation Act; Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); SENATE; Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); White House Office; Food & Drug Administration (FDA)

Medical/Disease Research/Clinical Labs MED

NIH; FDA

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Executive Office of the President (EOP); White House Office; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC)

Torts TOR

Medical Liability Reform; Protecting Access to Care Act; Good Samaritan Health Professionals Act

LobbyistCovered position, as disclosed
RYAN MCBRIDE Lobbyist
JOHN MICHAEL C. VILLARAMA Lobbyist
LAURA WOOSTER Sr. Vice President Public Policy

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.